Veru PE ratio VERU

Share price divided by earnings per share over the last twelve months, since 2012.

Today, Oct 23, 2026: n/m; not a meaningful number
Last meaningful: 48.5×; Feb 2022
Peer median: 11.1×

Veru's PE ratio is not a meaningful number today: diluted EPS for one or more of the four quarters through 2026-06-30 is missing, so twelve months can't be added up.

It was last meaningful in Feb 2022, at 48.5×.

PE ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2022	48.5×	43.1×	53.5×
2021	53.5×	53.5×	57.6×
2020	n/m a value too high to mean anything
2019	n/m a value too high to mean anything
2018	n/m a value too high to mean anything
2017	105×	99.0×	113×
2016	91.0×	7.9×	103×
2015	9.7×	9.4×	63.7×
2014	48.6×	10.8×	51.1×
2013	17.1×	11.8×	18.1×
2012	13.0×	12.6×	19.7×

Against its peers

Companies in Drug Manufacturers - General nearest Veru's size, closest first, today.

Company	PE ratio
VERUVeru	n/m
ATNMActinium Pharmaceuticals	4.2×
SPROSpero Therapeutics	10.1×
LFVNLifevantage	14.7×
NATRNatures Sunshine Products	12.0×
Peer median	11.1×

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on Veru

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.